Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Granulomatous slack skin responds to UVA1 phototherapy.

Oberholzer PA, Cozzio A, Dummer R, French LE, Hofbauer GF.

Dermatology. 2009;219(3):268-71. doi: 10.1159/000226135. Epub 2009 Jun 23.

2.

Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma.

Plettenberg H, Stege H, Megahed M, Ruzicka T, Hosokawa Y, Tsuji T, Morita A, Krutmann J.

J Am Acad Dermatol. 1999 Jul;41(1):47-50.

PMID:
10411410
3.

Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study.

Breuckmann F, von Kobyletzki G, Avermaete A, Kreuter A, Altmeyer P.

Photodermatol Photoimmunol Photomed. 2002 Oct;18(5):217-22.

PMID:
12390661
4.

Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.

Andres C, Kollmar A, Mempel M, Hein R, Ring J, Eberlein B.

Br J Dermatol. 2010 Feb 1;162(2):445-7. doi: 10.1111/j.1365-2133.2009.09438.x. Epub 2009 Aug 8.

PMID:
19785603
5.

Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.

Kreuter A, Hyun J, Skrygan M, Sommer A, Tomi NS, Breuckmann F, Altmeyer P, Gambichler T.

Arch Dermatol Res. 2006 Nov;298(6):265-72. Epub 2006 Sep 19.

PMID:
17009056
6.

[Ultraviolet-A1 (UVA1) phototherapy in lichen sclerosus et atrophicus].

Kreuter A, von Kobyletzki G, Happe M, Herde M, Breuckmann F, Stücker M, Altmeyer P.

Hautarzt. 2001 Oct;52(10):878-81. German.

PMID:
17690817
7.

Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy.

Breuckmann F, von Kobyletzki G, Avermaete A, Pieck C, Kreuter A, Brockmeyer NH, Altmeyer P, Gambichler T.

Eur J Med Res. 2002 Jul 24;7(7):315-22.

PMID:
12176681
8.

Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.

Abeck D, Schmidt T, Fesq H, Strom K, Mempel M, Brockow K, Ring J.

J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):254-7.

PMID:
10642681
9.

Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma.

Su O, Onsun N, Onay HK, Erdemoglu Y, Ozkaya DB, Cebeci F, Somay A.

Int J Dermatol. 2011 Aug;50(8):1006-13. doi: 10.1111/j.1365-4632.2010.04843.x.

PMID:
21781079
10.

[Phototherapy in severe atopic dermatitis. Comparison between current UVA1 therapy, UVA1 cold light and combined UVA-UVB therapy].

von Kobyletzki G, Freitag M, Herde M, Höxtermann S, Stücker M, Hoffmann K, Altmeyer P.

Hautarzt. 1999 Jan;50(1):27-33. German.

PMID:
10068928
11.

Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis.

von Kobyletzki G, Pieck C, Hoffmann K, Freitag M, Altmeyer P.

J Am Acad Dermatol. 1999 Dec;41(6):931-7.

PMID:
10570376
12.

Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.

Morita A, Kobayashi K, Isomura I, Tsuji T, Krutmann J.

J Am Acad Dermatol. 2000 Oct;43(4):670-4.

PMID:
11004624
13.

Granulomatous slack skin: a distinct disorder or a variant of mycosis fungoides?

Topar G, Zelger B, Schmuth M, Romani N, Thaler J, Sepp N.

Acta Derm Venereol. 2001 Jan-Feb;81(1):42-4.

PMID:
11411914
14.

Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea.

Kreuter A, Gambichler T, Avermaete A, Jansen T, Hoffmann M, Hoffmann K, Altmeyer P, von Kobyletzki G, Bacharach-Buhles M.

Pediatr Dermatol. 2001 May-Jun;18(3):241-5.

PMID:
11438008
15.

UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V.

Jacobe HT, Cayce R, Nguyen J.

Br J Dermatol. 2008 Sep;159(3):691-6. doi: 10.1111/j.1365-2133.2008.08672.x. Epub 2008 Jun 7.

PMID:
18544076
16.

Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study.

Gobello T, Mazzanti C, Sordi D, Annessi G, Abeni D, Chinni LM, Girolomoni G.

J Am Acad Dermatol. 2003 Oct;49(4):679-84.

PMID:
14512916
17.

Efficacy of UVA1 phototherapy in 230 patients with various skin diseases.

Rombold S, Lobisch K, Katzer K, Grazziotin TC, Ring J, Eberlein B.

Photodermatol Photoimmunol Photomed. 2008 Feb;24(1):19-23. doi: 10.1111/j.1600-0781.2008.00328.x.

PMID:
18201353
18.

Dramatic response of chronic ulcerating necrobiosis lipoidica to ultraviolet A1 phototherapy.

Radakovic S, Weber M, Tanew A.

Photodermatol Photoimmunol Photomed. 2010 Dec;26(6):327-9.

PMID:
21140992
19.

Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.

Kreuter A, Hyun J, Skrygan M, Sommer A, Bastian A, Altmeyer P, Gambichler T.

Br J Dermatol. 2006 Sep;155(3):600-7.

PMID:
16911288
20.

A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.

Kreuter A, Hyun J, Stücker M, Sommer A, Altmeyer P, Gambichler T.

J Am Acad Dermatol. 2006 Mar;54(3):440-7. Epub 2006 Jan 30.

PMID:
16488295

Supplemental Content

Support Center